logo
‘King Kong' of fat jabs ‘help you TONE up' – as scientists discover surprising ‘fitness boost'

‘King Kong' of fat jabs ‘help you TONE up' – as scientists discover surprising ‘fitness boost'

The Sun11 hours ago
ALONG with rapid fat loss, weight loss jabs have been linked to a decrease in muscle mass.
But scientists say one injection - known as the 'King Kong' of weight loss jabs - may swerve this side effect.
2
In fact, it could help users tone up, researchers from the University of Glasgow said.
Their study analysed the body composition of more than 200 people and found they lost no more muscle from the weight loss jab Mounjaro than if they had lost weight a different way.
It suggested muscle loss from shedding weight will be similar with or without the injections.
But researchers also noticed that Mounjaro-users also lost fat from inside their muscles - much more than they would have done from losing weight without the medicines.
Getting rid of the fat marbling muscles may improve how they work and boost people's ability to exercise, scientists said.
That's because the fat that gets into muscles and surrounds vital organs - which is different from the fat layer just beneath the skin - has been linked with muscle weakness and poorer physical performance.
The study's lead author Naveed Sattar, a professor of metabolic medicine at Glasgow University's Institute of Cardiovascular and Medical Sciences, told The Times: 'For the majority of people using the weight-loss injection tirzepatide [the active ingredient in Mounjaro], they experience an increase in their capacity for activity, meaning they can often walk for longer or be more active than before.
'Having less muscle fat usually means the remaining fat muscle cells are more efficient in generating power, which could explain the boost to people's exercise abilities.
"These results are hugely encouraging as less muscle fat is also linked to a reduced risk of cardiovascular disease and type 2 diabetes in many studies.
'However, we don't yet know how weight-loss injections remove additional muscle fat, and more evidence is needed to understand the mechanisms involved.'
When someone is overweight or not very active, they're more likely to get streaks of fat in their muscles.
It's possible to reduce it by doing aerobic exercise such as jogging, walking and cycling.
But for people have difficulty exercising due to their weight or other conditions, using weight loss jabs to get rid of muscle fat holds promise.
The study, published in The Lancet Diabetes & Endocrinology, was conducted at 45 medical research centres and hospitals in eight countries - including Greece, Hungary, Italy, Romania, Spain and the US.
It assessed 246 people with type 2 diabetes who were either given varying doses of Mounjaro - 5 mg, 10 mg, or 15 mg - once a week, or daily insulin injections.
Researchers used MRI scans to measure amount of muscle and fat each person had in their thighs before the treatment, and a year after starting it.
They compared muscle loss in tirzepatide users to typical muscle loss in people of the same age and sex, who lost the same amount of weight without the jabs - using the data of 3,000 people from the UK Biobank study.
Both groups lost a similar amount of muscle.
Everything you need to know about fat jabs
Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases.
Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK.
Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market.
Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year.
How do they work?
The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight.
They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists.
They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high.
Can I get them?
NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics.
Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure.
GPs generally do not prescribe the drugs for weight loss.
Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk.
Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health.
Are there any risks?
Yes – side effects are common but most are relatively mild.
Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea.
Dr Sarah Jarvis, GP and clinical consultant at patient.info, said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.'
Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia.
Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health.
Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines.
But Mounjaro-takers lost 0.5 per cent more fat from within their muscles.
Researchers didn't assess participants' ability to exercise after taking the jabs.
"As the study was not specifically designed to evaluate muscle-related changes, assessments of strength, mobility, and physical performance are not available," they wrote.
They also said other factors may have lead to loss of fat within muscles.
"There were no specific instructions in our study about dietary changes or exercise training beyond the standard of care at each site and region, and we cannot exclude the influence that individual differences in lifestyle management might have had on the results," scientists wrote.
"It has been reported that resistance exercise training or dietary supplements might exert a positive effect on muscle composition, and are recommended when substantial weight reduction is achieved or expected (eg. after bariatric surgery)."
The findings indicate that Mounjaro gets rid of fat from different parts of the body better than conventional weight loss, scientists said, as well as dimming hunger pangs.
That could help to explain evidence suggesting weight-loss injections may reduce the risk of diabetes and many other chronic diseases.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Patients will suffer most if doctor strikes resume, NHS bosses warn
Patients will suffer most if doctor strikes resume, NHS bosses warn

Times

time39 minutes ago

  • Times

Patients will suffer most if doctor strikes resume, NHS bosses warn

NHS bosses have warned that patients will be the ones to 'suffer most' from another wave of doctors' strikes as they nervously await the results of a ballot. The British Medical Association is expected to announce results of its ballot of about 50,000 resident doctors, who were formerly known as junior doctors, on Tuesday. The ballot closed at 12pm on Monday and if passed, would give resident doctors a six-month mandate to call strike action until the New Year, with strikes held from July 21 at the earliest. The result is expected to be close, with NHS bosses hopeful that turnout may not pass the 50 per cent threshold required for industrial action. However, BMA leaders have said that they are confident it will pass and that doctors are 'excited to go again'.

Swinney an ‘analogue politician in a digital age' says Streeting
Swinney an ‘analogue politician in a digital age' says Streeting

Telegraph

timean hour ago

  • Telegraph

Swinney an ‘analogue politician in a digital age' says Streeting

John Swinney, the First Minister, has been described by the UK Health Secretary as an 'analogue politician in a digital age' in a row over the Scottish Government's failure to create an NHS app. Wes Streeting said there was 'no excuse' for the devolved government not to have introduced an app that allows patients to book appointments with their GP, order prescriptions and manage hospital appointments. A similar app was rolled out in England six years ago. Plans to create an NHS Scotland app are underway but are currently limited to a trial for dermatology patients in NHS Lanarkshire. A national rollout is not expected before the end of the decade. Mr Streeting warned patients in Scotland are 'missing out' and said it showed why Scotland 'can't afford a third decade of the SNP'. He is the first senior Westminster politician to publicly criticise the running of Scotland's NHS, which has been under fire for lengthy waits. Mr Streeting said: 'The UK Labour Government is embracing technology to deliver a better NHS for patients and their families, giving them more control and transparency over their treatment. 'In John Swinney, the SNP have an analogue politician in a digital age, and patients in Scotland are missing out. 'The SNP have record funding and complete control of the NHS in Scotland, there's no excuse for this, and it just shows why Scotland can't afford a third decade of the SNP and needs a new direction with Anas Sarwar as first minister.' It is not the first time that Scotland's First Minister has been accused of being slow to bring the Scottish NHS into the 21st century. Earlier this year, Ian Murray, the Scottish Secretary, made similar remarks after GPs said they looked 'on with frustration' at the digital health tech divide between England and Scotland, citing the delay in launching tools such as the NHS Scotland app. Mr Streeting has pledged to improve the use of technology in the NHS south of the border and last week announced improvements to the country's NHS app, which already has 35 million users. Sir Keir Starmer, the Prime Minister, said the app would 'become, as technology develops, like having a doctor in your pocket, providing you with 24-hour advice, seven days a week'. The 'supercharged' version of the app is promised to be delivered by 2028 and is expected to allow patients to book and check hospital appointments, interact with specialists or visit an 'AI doctor' for advice. An app for the Scottish health service, announced in 2021, is not expected to launch on a trial basis until December. Its functionality will initially be severely restricted, with its only practical purpose being to allow dermatology patients served by one health board, NHS Lanarkshire, to be notified of appointments. If successful, rollouts will continue in other areas until its full introduction in five years. 'Sustained improvements for patients' According to the latest official health statistics, the number of patients waiting more than 78 weeks for treatment in Scotland has increased to 38,070, while in England the figure has halved to 1,154. Cancer treatment waiting time standards are also being missed. A spokesperson for Neil Gray, the Scottish Health Secretary said: 'Scotland's planned online app is for both health and social care and we will launch it in Lanarkshire by the end of 2025. 'National rollout will commence through 2026 and we will publish a national rollout plan later this summer. 'We will leave Labour to carry out personal attacks – the SNP Government's focus is on putting in place the lasting solutions which will deliver sustained improvements for patients. 'As Wes Streeting knows, Scotland's core A&E performance has been the best in the UK for the last 10 years, we have more GPs per head than south of the border, and we are building on this with record funding for health and social care this year.'

NHS to use robots on obese patients during surgery as it's safest way to operate on them
NHS to use robots on obese patients during surgery as it's safest way to operate on them

The Sun

time2 hours ago

  • The Sun

NHS to use robots on obese patients during surgery as it's safest way to operate on them

THE NHS will use surgical robots to get more fat Brits on the operating table because machines can work on people who are too high-risk for manual procedures. They use smaller instruments and enter through smaller incisions, and can be faster so patients do not need as much anaesthetic. 3 3 Robotics is one of the Government's 'five big bets' on technology that will revolutionise the NHS. Ministers' 10-Year Plan for the health service, launched last week, said it will 'expand surgical robot adoption'. NHS watchdog the National Institute for Health and Care Excellence (Nice) has encouraged hospitals to invest more in surgical robots and use them more widely. A recent report by NHS England added: 'Robot-assisted surgery may improve access to surgery for people who are at higher risk, including people with a high body mass index.' Body mass index is a height-to-weight ratio, with any number higher than 30 classed as obese. About three in 10 adults in England are obese and this puts them at higher risk during operations and may even mean they can't have them. Bulky fat means it takes longer to conduct super-precise surgery and large patients need more anaesthetic and lose more blood. Top prostate surgeon Ben Challacombe, who works at Guy's and St Thomas' NHS Trust in London, said: 'Operating on obese patients is highly complex and more tricky. 'When you're obese you're much more likely to get an infection or to have breathing difficulties because your lungs are being squashed by other tissues. 'Robotic assistance means we can do more. 'We can do robotic surgery on much bigger patients than we could with traditional keyhole surgery.' Jeffrey Ahmed, a gynaecological surgeon at Chelsea and Westminster NHS Trust, said: 'Some patients are too obese to have an operation, because to do a big open operation on someone whose BMI is 65 subjects them to too much risk. 'The minimally invasive approach that we can do on the robot opens up the possibility of doing that kind of care for patients. 'I think it will be used more in the future. 'If you can't physically do an operation for a patient without a robot, then that's going to be the way to do it. 'You can't just not offer the patient surgery because you don't have access to a robot.' Robot-assisted surgery relies on qualified surgeons controlling the £1m machines with the usual medical team around the patient. There are about 140 machines in use in England and their use has rocketed from 35,000 operations in 2022 to 70,000 in 2024. Dr Chris Smith-Brown, from the Private Healthcare Information Network, added: 'We know that losing weight is not always possible. 'There is hope that obesity won't have to be a barrier to life-changing surgery.' 3

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store